-
[Illinois] Cancer Community Symposium 2012: DriveRank: Discovering Patient-Specific Driver Mutations
Online Presentations | 09 May 2012 | Contributor(s):: Jack Pu Hou
One of the pressing challenges in cancer genomics is to distinguish driver mutations (i.e. mutations involved in tumorigenesis) and passenger mutations (i.e. functionally neutral mutations). Current approaches to identifying driver mutations in cancer look for recurrent events in multiple...
-
[Illinois] Cancer Community Symposium 2012: Elevated Estrogen Signaling Drives Tumorigenesis in a Novel Animal Model for Ovarian Epithelial Cancer
Online Presentations | 09 May 2012 | Contributor(s):: Mary Jo Laws
We generated a mouse model where aberrant estrogen receptor alpha (Esr1) signaling in the hypothalamo-pituitary-ovarian axis leads to ovarian tumorigenesis. In this model, termed Esr1d/d, the Esr1 gene is selectively deleted in the anterior pituitary. The Esr1d/d mice form palpable ovarian tumors...
-
2005 Oncological Sciences Center Symposium
Workshops | 16 Aug 2005
Progress and Problems inCancer Treatment and Prevention
-
2005 Oncological Sciences Center Symposium Agenda
Downloads | 07 Dec 2006
-
2008 BioNano Technology and Pharmaceuticals
Workshops | 06 Aug 2008 | Contributor(s):: Pankaj Sharma, Nalam Madhusudhana Rao
The purpose of this symposium is to bring together top scientists from India and the United States to present their latest work and to discuss future international scientific collaborative partnerships. This one and a half day symposium will also feature a special second half day mini-symposium...
-
Nov 16 2015
4th Oncology Partnering & Deal-Making Conference
Dear Colleague,We invite you to attend the 4th Oncology Partnering & Deal-Making Conference, which will take place November 16-17, 2015 in San Francisco, CA. This event is a partnership and...
https://nanohub.org/events/details/1375
-
Jul 07 2014
5th Cancer Targets & Therapeutics Conference
With the rapid progression of molecular biology and genetics, and the subsequent emergence of many new targets, emerging targets and therapeutics provide new opportunities for the prevention and...
https://nanohub.org/events/details/970
-
A Computational model of EGFR and IGF1R pathways in lung cancer
Tools | 06 Dec 2022 | Contributor(s):: Supriya Bidanta, FNU POORVA, Dhanusha Duraiyan
A Computational model of EGFR and IGF1R pathways in lung cancer
-
Antiestrogenic Conjugates as New Breast Cancer Chemoprevention Agents
Online Presentations | 08 Mar 2007 | Contributor(s):: Ross Weatherman
Tamoxifen is the first drug specifically approved for the prevention of cancer and arguably the most successful anticancer drug of all time. Although millions of breast cancer patients have benefited from tamoxifen therapy, there are side effects that hinder the broad use of tamoxifen as a...
-
Birck Science Communication Shark Tank Compititon 2018
Online Presentations | 17 Jan 2019
The Science Communication Shark Tank competition and workshop gives students a chance to learn and train master storyteller skills in the best possible way: by playing a real-life game.
-
BME 695L Lecture 13: Designing Nanomedical Systems (NMS) for In-vivo Use
Online Presentations | 22 Nov 2011 | Contributor(s):: James Leary
See references below for related reading.13.1 Bringing in-vivo considerations into NMS design13.1.1 the in-vitro to ex-vivo to in-vivo paradigm 13.1.1.1 In-vitro - importance of choosing...
-
BME 695L Lecture 14: Designing and Testing Integrated Nanomedical Systems
Online Presentations | 22 Nov 2011 | Contributor(s):: James Leary
See references below for related reading.14.1 Introduction to integrated designs14.1.1 “Total design” but there is some order in the design process14.1.2 A brief outline of the total design...
-
BME 695L Special Lecture 3: In vivo Model Systems to Study Nanomedical Approaches to Cancer Detection and Intervention
Online Presentations | 02 Dec 2011 | Contributor(s):: Deborah W Knapp
Guest lecturer: Deborah Knapp.
-
BME 695L: Engineering Nanomedical Systems
Courses | 31 Aug 2011 | Contributor(s):: James Leary
This course will cover the basic concepts of design of integrated nanomedical systems for diagnostics and therapeutics. Topics to be covered include: why nanomedical approaches are needed, cell targeting strategies, choice of core nanomaterials, technologies for testing composition and structure...
-
BME 695N Lecture 18: Designing nanodelivery systems for in-vivo use
Online Presentations | 12 Nov 2007 | Contributor(s):: James Leary
Outline:Overview – the in-vitro to ex-vivo to in-vivo paradigm In-vitro - importance of choosing suitable cell lines Ex-vivo – adding the complexity of in-vivo background while keeping the simplicity of in-vitro In-vivo - all the complexity of ex-vivo plus the “active” components of a real...
-
BME 695N Lecture 19: In vivo model systems to study nanomedical approaches to cancer detection and intervention
Online Presentations | 27 Nov 2007 | Contributor(s):: Deborah W Knapp
With Deborah Knapp as guest lecturer.
-
BME 695N: Engineering Nanomedical Systems (Fall 2007)
Courses | 03 Aug 2007 | Contributor(s):: James Leary
This course will cover the basic concepts of design of integrated nanomedical systems for diagnostics and therapeutics. Topics to be covered include: why nanomedical approaches are needed, cell targeting strategies, choice of core nanomaterials, technologies for testing composition and...
-
Cancer Care Engineering
Online Presentations | 31 Jan 2011 | Contributor(s):: Joseph Pekny
-
Cancer Games: Interactive Simulation of the Effect of Resource Limitation on Cancer Somatic Evolution using nanoHUB CompuCell3D
Online Presentations | 04 Feb 2021 | Contributor(s):: James A Glazier
In this interactive mini-workshop we will use a very simple model of cancer somatic evolution and resource limitation based on one originally proposed by Heiko Enderling.
-
CompuCell3D - Avascular Tumor Growth and Mutation
Tools | 07 Aug 2021 | Contributor(s):: Juliano Ferrari Gianlupi
Avascular tumor, growing on nutrient, self-limited, mutates